Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

November 7, 2023

Study Completion Date

November 14, 2023

Conditions
General Anesthesia
Interventions
DRUG

HSK3486

HSK3486 for induction of general anesthesia

DRUG

Propofol

Propofol for induction of general anesthesia.

Trial Locations (23)

21122

Chesapeake Research Group, Llc, Pasadena

27710

Duke University Health, Durham

32250

Coastal Clinical Research Specialists, Jacksonville

33136

University of Miami Hospital, Miami

33321

Phoenix Clinical Research, Tamarac

33613

ForCare Clinical Research, Tampa

34232

Gulfcoast Research Institute, Llc, Sarasota

35660

Shoals Medical Trials, Inc., Sheffield

43210

The Ohio State University Wexner Medical Center, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

45417

Midwest Clinical Research Center, Dayton

60612

Rush University Medical Center, Chicago

67226

NextStage Clinical Research - Abay Neuroscience Center, Wichita

75006

Hd Research Llc., Carrollton

77030

The University of Texas - MD Anderson Cancer Center, Houston

77401

HD Research, Bellaire

78229

Urology San Antonio Research, San Antonio

78240

Endeavor Clinical Trials, San Antonio

84107

Jbr Clinical Research, Salt Lake City

85053

Arizona Research Center, Phoenix

95616

UC Davis Health, Davis

97239

Oregon Health & Science University, Portland

02115

Brigham & Women'S Hospital, Boston

All Listed Sponsors
lead

Haisco-USA Pharmaceuticals, Inc.

INDUSTRY